Tumor Immunology and Immunotherapy
Tumor Immunology and Immunotherapy is a rapidly growing field in cancer research, focusing on harnessing the body's immune system to fight cancer. The idea behind tumor immunotherapy is to enhance the ability of the immune system to recognize and target cancer cells, ultimately leading to more effective treatments. This can be achieved through a variety of methods, such as stimulating the immune system to attack cancer cells directly, using immunomodulatory drugs to enhance immune responses, or engineering immune cells to better target cancer cells. The success of immunotherapy has led to significant advancements in the field of cancer treatment, and it is widely recognized as a cornerstone of modern oncology. With ongoing research, we are poised to make more breakthrough discoveries that will benefit even more patients. CRTOH, with its focus on multidisciplinary and interdisciplinary research, is well-positioned to play a key role in these exciting developments in the field of cancer research.
Our researchers
Grid view
-
Prof. Alfredo Addeo
-
-
Prof. Carole Bourquin
-
Prof. Santiago Carmona
Combination of data science methods development with high-throughput single-cell and spatial omics technologies
Prof. Santiago Carmona
-
-
-
Prof. Stéphanie Hugues
Lymphatic vessels in the regulation of tumor immunity, Group Leader
-
-
-
Dr. Raphaëlle Luisier
Genomics and Health Informatics, Idiap Research Institute, Martigny
-
-
Prof. Olivier Michielin
Full Professor, Department of Medicine, Faculty of Medicine UNIGE, Head, Division of Precision Oncology, HUG, Director, Department of Oncology, HUG,
-
Prof. Denis Migliorini
Head, Neuro Oncology Unit, HUG
Assistant Professor, Department of Oncology, UNIGE -
Prof. Mikaël Pittet
Understanding and manipulating the immune system to fight against cancer, group leader & CRTOH Coordinator
-
-
-
Dr. Federico Simonetta
Chef de Clinique Scientifique Oncology, Division of Hematology
Dr. Federico Simonetta
-
Prof. Pelagia Tsoutsou
0223727098
E-mail
-
-
List view
-
Addeo Alfredo
Consultant Oncologist , Tumor immunology and immunotherapy
-
Ansari Marc
Head of Oncology and Hematology Pediatric (HUG)
-
Bourquin Carole
Immunopharmacology of Cancer, Group leader
-
Carmona Santiago
Combination of data science methods development with high-throughput single-cell and spatial omics technologies
-
Dietrich Pierre-Yves
Professeur honoraire - Cancer Immunotherapy
-
Eberhardt Christiane
Group leader - Vaccinology Center
-
Hugues Stéphanie
Lymphatic vessels in the regulation of tumor immunity, Group Leader
-
Jandus Camilla
Tenure-track Assistant Professor
F07.3167.A -
Kössler Thibaud
Médecin adjoint, responsible d’unité Oncologie
-
Luisier Raphaëlle
Genomics and Health Informatics, Idiap Research Institute, Martigny
-
Mach Nicolas
Translational Research in Oncology, Group Leader
-
Michielin Olivier
Full Professor, Department of Medicine, Faculty of Medicine UNIGE, Head, Division of Precision Oncology, HUG, Director, Department of Oncology, HUG,
-
Migliorini Denis
Head, Neuro Oncology Unit, HUG
Assistant Professor, Department of Oncology, UNIGE -
Pittet Mikaël
Understanding and manipulating the immune system to fight against cancer, group leader & CRTOH Coordinator
-
Scheiermann Christoph
How the circadian cycle influences immunity
-
Serre-Beinier Véronique
Head of Division / Biologist
D02.1547.A -
Simonetta Federico
Chef de Clinique Scientifique Oncology, Division of Hematology
-
Tsoutsou Pelagia
Head of Radiation Oncology Department
-
Villard Jean
HUG Diagnostic, Affiliated member PATIM
-
Walker Paul
Immunobiology of Brain Tumours, group leader